ArticleNeuro-oncology advances
Deep learning-based postoperative glioblastoma segmentation and extent of resection evaluation: Development, external validation, and model comparison.
Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Study of Adaptive Radiotherapy for High-Grade Glioma Based on Interfraction MRI.Cancer medicine · 2026Trial
- Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.Clinical and translational radiation oncology · 2026Article
- Can 3D T1 Post-Contrast MRI in A Radiomics-Machine Learning Model Distinguish Infective from Neoplastic Ring-Enhancing Brain Lesions? An Exploratory Study.Diagnostics (Basel, Switzerland) · 2026Article
- Editorial: Intraoperative Visualization Techniques and Advanced Imaging in Brain Tumors.Cancers · 2026Article
- Editorial: Artificial intelligence in neurosurgical practices: current trends and future opportunities.Frontiers in neurology · 2026Article
- Calibrated and explainable multiparametric MRI radiomics for differentiating tumor positive disease from treatment-related changes in glioblastoma.Frontiers in oncology · 2026Article
- Radiomics-based quantification of tumor infiltration in the non-enhancing peritumoral region on postoperative MRI is associated with survival in glioblastoma.Scientific reports · 2025Article
- RANO 2.0: critical updates and practical considerations for radiological assessment in neuro-oncology.Japanese journal of radiology · 2025Review
- A Review on Deep Learning Methods for Glioma Segmentation, Limitations, and Future Perspectives.Journal of imaging · 2025Review
- Development and validation of a deep learning algorithm for discriminating glioma recurrence from radiation necrosis on MRI.Frontiers in oncology · 2025Article
- Noninvasive MGMT-promotor methylation prediction in high grade gliomas using conventional MRI and deep learning-based segmentations.Frontiers in neuroscience · 2025Article
- BrainTumNet: multi-task deep learning framework for brain tumor segmentation and classification using adaptive masked transformers.Frontiers in oncology · 2025Article
- MDPNet: a dual-path parallel fusion network for multi-modal MRI glioma genotyping.Frontiers in oncology · 2025Article
- Automatic and standardized reporting of perioperative MRIs in patients with central nervous system tumors.Frontiers in neurology · 2025Article
- Validation of open-source deep learning segmentation tools for automated glioma volumetry: a narrative review of Dice scores, workflow efficiency, and clinical RANO 2.0 implementation.Frontiers in neurologyReview
- Role of the frontal aslant tract in language preservation and recovery after surgery: a multicenter analysis of patients with left frontal glioma.Frontiers in neurologyArticle
- Diagnosing growth in low-grade gliomas with and without artificial intelligence-measured longitudinal volume measurements: A retrospective observational study.Neuro-oncology advancesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The pursuit of automated methods to assess the extent of resection (EOR) in glioblastomas is challenging, requiring precise measurement of residual tumor volume. Many algorithms focus on preoperative scans, making them unsuitable for postoperative studies. Our objective was to develop a deep learning-based model for postoperative segmentation using magnetic resonance imaging (MRI). We also compared our model's performance with other available algorithms. Methods: To develop the segmentation model, a training cohort from 3 research institutions and 3 public databases was used. Multiparametric MRI scans with ground truth labels for contrast-enhancing tumor (ET), edema, and surgical cavity, served as training data. The models were trained using MONAI and nnU-Net frameworks. Comparisons were made with currently available segmentation models using an external cohort from a research institution and a public database. Additionally, the model's ability to classify EOR was evaluated using the RANO-Resect classification system. To further validate our best-trained model, an additional independent cohort was used. Results: The study included 586 scans: 395 for model training, 52 for model comparison, and 139 scans for independent validation. The nnU-Net framework produced the best model with median Dice scores of 0.81 for contrast ET, 0.77 for edema, and 0.81 for surgical cavities. Our best-trained model classified patients into maximal and submaximal resection categories with 96% accuracy in the model comparison dataset and 84% in the independent validation cohort. Conclusions: Our nnU-Net-based model outperformed other algorithms in both segmentation and EOR classification tasks, providing a freely accessible tool with promising clinical applicability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.